Bavarian Nordic
191.85 DKK
+0.95 %
Less than 1K followers
BAVA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+0.95 %
-18.36 %
-19.05 %
+6.35 %
+1.32 %
+3.15 %
-20.53 %
+7.30 %
+34.51 %
Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.
Read moreMarket cap
15.2B DKK
Turnover
31.38M DKK
Revenue
5.72B
EBIT %
16.44 %
P/E
15.23
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
All
Research
Webcasts
Press releases
ShowingAll content types
Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million
Bavarian Nordic vil foretage aktietilbagekøb for op til DKK 500 mio.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
